Euroapi S.A. (EPA:EAPI)

Market Cap	274.55M
Revenue (ttm)	919.20M
Net Income (ttm)	-130.60M
Shares Out	95.26M
EPS (ttm)	-1.38
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	87,283
Average Volume	207,353
Open	2.850
Previous Close	2.858
Day's Range	2.838 - 2.914
52-Week Range	2.500 - 4.540
Beta	0.67
RSI	56.91
Earnings Date	Jul 29, 2025

About Euroapi

Euroapi S.A. develops, manufactures, markets, and distributes active pharmaceutical ingredients and intermediates used in the formulation of medicines for human and veterinary use. It provides contract development manufacturing organization for different classes of tides that uses solid phase chemistry; particle engineering; microbial fermentation; small molecules synthesis; prostaglandins; steroids and hormones; and opiates and controlled substances, as well as lipids. The company was incorporated in 2020 and is based in Paris, France.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2020
• Employees: 3,329
• Stock Exchange: Euronext Paris
• Ticker Symbol: EAPI

Financial Performance

In 2024, Euroapi's revenue was 919.20 million, a decrease of -9.79% compared to the previous year's 1.02 billion. Losses were -130.60 million, -31.15% less than in 2023.